iShares Genomics Immunology and Healthcare ETF
Limited financial coverage for IDNA.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
- IPO
- 2019
- HQ
- San Francisco, CA, US
Get TickerSpark's AI analysis on IDNA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $197.73M
- Div Yield
- 0.67%
- 52W High
- $43.44
- 52W Low
- $23.90
- 50D MA
- $38.65
- 200D MA
- $32.06
- Beta
- 1.11
- RSI (14)
- 59
- Avg Volume
- 114.08K
No earnings-call transcripts are available for IDNA yet.
- Free Float
- 0.0%
- Shares Outstanding
- 4.69M
- Float Shares
- 0
of shares held by institutions
61 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Ubs Group AG | 493.57K | ▲ 6.80K |
| Bank Of America Corp | 467.00K | ▲ 8.31K |
| Wharton Business Group, LLC | 268.47K | ▼ 1.51K |
| Jane Street Group, LLC | 114.93K | ▲ 114.93K |
| Ameriprise Financial Inc | 111.05K | ▼ 3.28K |
| Portland Global Advisors LLC | 105.30K | ▲ 1.17K |
| Wells Fargo & Company/Mn | 95.35K | ▲ 70.49K |
| Trek Financial, LLC | 90.94K | ▲ 90.94K |
| Royal Bank Of Canada | 88.54K | ▲ 36.69K |
| Morgan Stanley | 81.34K | ▼ 12.87K |
| Raymond James Financial Inc | 75.46K | ▼ 1.15K |
| Lpl Financial LLC | 71.50K | ▼ 1.04K |
Our IDNA coverage
Recent articles, reports, and earnings notes.
No research on IDNA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IDNA report →Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs
benzinga.com · Sep 1
Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
zacks.com · Sep 1
IDNA: 3 Catalysts To Watch Closely
seekingalpha.com · Aug 21
iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Up 428.3% in January
defenseworld.net · Jan 28
IDNA: The Cutting Edge Of Medical Science Is A Risky Investment
seekingalpha.com · Apr 20
Disruptive Theme of the Week – Breakthroughs in Medicine
etftrends.com · Nov 21
IDNA: Healthcare Dashboard For February
seekingalpha.com · Feb 18
Disruptive Tech Theme of the Week: 7 Disruptive Themes for 2024
etftrends.com · Dec 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.